Update to Faron’s Financial Calendar and date of the Annual General Meeting in 2026
Faron Pharmaceuticals Ltd. has updated its 2026 financial calendar, rescheduling its Annual General Meeting to May 4, 2026, from the previously announced March 30, 2026 date. The publication of the company's half-year financial report for the period ending June 30, 2026, remains unchanged and is scheduled for August 26, 2026.
Select text to share a quote on X · sign in to keep highlights & notes in your FARN notes
| Faron Pharmaceuticals Ltd | Company announcement | March 09, 2026 at 19:45:00 EET |
TURKU, FINLAND - Faron Pharmaceuticals Ltd. (AIM: FARN, First North: FARON), a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, today announces an update for the Company’s financial calendar 2026.
The Annual General Meeting is now planned to take place on 4 May 2026, instead of 30 March 2026 as previously communicated. Faron’s Board of Directors will issue a separate company announcement in due course to formally convene the meeting.
The publication date of Faron’s half-year financial report for the period January 1 to June 30, 2026, remains unchanged being Wednesday 26 August 2026.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.